dr. reddy's labs glp-1 receptor agonists weight management diabetes treatments Laboratories Launches Obeda: A Breakthrough in Type 2 Treatment, ETPharma Walking on 'Thin' Ice: DHC
Description
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
Learn what retatrutide does and how it affects appetite, blood sugar and energy use
Is microdosing semaglutide or tirzepatide safe
Jardiance (empagliflozin) 38% CV death reduction vs Mounjaro (tirzepatide) 21% weight loss (EMPA-REG vs SURPASS)
As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)
They stimulate insulin secretion and inhibit glucagon secretion by elevating e...
